News

According to UBS, the company’s next major driver is the SURPASS cardiovascular outcomes trial. The bank added that Eli Lilly ...
Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR ...
Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...
Union momentum grows in Ireland’s €100bn pharma sector as Trump’s tariff threats and weak labour laws fuel worker unrest ...
India is among the top two countries in terms of type 2 diabetes cases and third in terms of obesity; hence, the need for ...
Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...
Novo Nordisk NVO has experienced remarkable growth in recent years, largely fueled by the commercial success of its ...
Senate bill would add at least $3.3 trillion to the national debt, according to the Congressional Budget Office. That was the ...
Brandy Was a Hit Drink. Now It's a Poster Child for the Trade Wars. The preferred quaff of aristocrats and rappers is a key export for European luxury-drink makers, which are fighting tariff assaults ...
The acquisition of Pension Insurance Corp. would effectively turn the specialist insurer into Athora's U.K. insurance business. A court-appointed special master recommended a bid backed by Gold ...